Influence of Age and Histology on Outcome in Adult Non-Hodgkin Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation (HCT): A Report from The Center For International Blood & Marrow Transplant Research (CIBMTR)

This publication has 37 references indexed in Scilit:

• Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma
  Bone Marrow Transplantation, 2006
• Follicular Lymphoma International Prognostic Index
  Blood, 2004
• HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen
  Blood, 2003
• Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (⩾60 years) with non-Hodgkin’s lymphoma: comparison with patients <60 years treated within the same protocol
  Bone Marrow Transplantation, 2000
• Analysis of feasibility of myeloablative therapy and autologous peripheral stem cell (PBSC) transplantation in the elderly: an interim report
  Bone Marrow Transplantation, 1999
• Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot study
  Bone Marrow Transplantation, 1998
• Treatment-related mortality in 1000 consecutive patients receiving high-dose chemotherapy and peripheral blood progenitor cell transplantation in community cancer centers
  Bone Marrow Transplantation, 1997
• Peripheral blood stem cell transplantation for relapsed or refractory aggressive lymphoma in patients over 60 years of age
  Bone Marrow Transplantation, 1997
• Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1995
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958